Researchers from the Case Western Reserve University (OH, USA) have demonstrated how a computer program can suggest novel cancer treatments.
Browsing: Taxonomy > Drug development
In this interview with the Vice President of Global Development at Amgen we take a more in-depth look at the trastuzumab data, an oncology biosimilar medicine.
This article first reviews the brief achievements in using albendazole to treat parasites and cancers, and summarizes the basic mechanisms of action of albendazole.
What is the potential clinical significance of the results of the FLAURA trial presented at ESMO? Find out in our exclusive interview.
A nationwide study across Ireland revealed that the vast majority of patients do not understand the core concepts underpinning a clinical trial.
We spoke with a key study investigator of the multiple myeloma ENDEAVOR trial to explore the trial in more detail and to discover the potential clinical application of its overall survival findings.
Drugs used to treat heart and blood vessel problems have shown promise in combination with chemotherapy for acute myeloid leukemia treatment.
Researchers at Sanford Burnham Prebys Medical Discovery Institute (CA, USA) have published a study shedding new light on how the anti-cancer agent K-80003 (TX803) inhibits cancer cell growth.
As part of our recent Spotlight focus on biosimilars in oncology, we asked you to share your thoughts and opinions on the role of biosimilars in oncology. Thanks to all who shared your thoughts with us – the results have been translated into this summary infographic.